Alembic Pharmaceuticals receives USFDA Final Approval for Do

Alembic Pharmaceuticals Limited today announced that it has received final approval from the USFDA for its ANDA for Doxycycline Hyclate Delayed-Release Tablets USP, 75 mg, 100 mg, 150 mg, and 200 mg.

Related Keywords

, Alembic Pharmaceuticals Limited , Alembic Pharmaceuticals , Us Food Drug Administration , Mayne Pharma International Pty , Pharmaceuticals Limited , Drug Administration , Abbreviated New Drug Application , Doxycycline Hyclate Delayed Release Tablets , Doryx Tablets , Mayne Pharma International , Doxycycline Hyclate Delayedrelease Tablets , Alembicpharmaceuticals , Ine901l01018 , Usfda , Panda , Finalapproval , Doxycyclinehyclate , Delayedreleasetablets ,